Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM
-
Number of holders
-
126
-
Total 13F shares, excl. options
-
112,055,640
-
Shares change
-
-2,322,821
-
Total reported value, excl. options
-
$236,191,249
-
Value change
-
-$40,079,104
-
Put/Call ratio
-
52%
-
Number of buys
-
63
-
Number of sells
-
-80
-
Price
-
$2.11
Significant Holders of OREXIGEN THERAPEUTICS INC - COM (OREX) as of Q3 2015
187 filings reported holding OREX - OREXIGEN THERAPEUTICS INC - COM as of Q3 2015.
OREXIGEN THERAPEUTICS INC - COM (OREX) has 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 112,055,640 shares
.
Largest 10 shareholders include STATE STREET CORP (11,780,717 shares), FMR LLC (11,598,705 shares), PRICE T ROWE ASSOCIATES INC /MD/ (6,491,715 shares), SAMLYN CAPITAL, LLC (6,160,417 shares), VANGUARD GROUP INC (4,599,187 shares), BlackRock Fund Advisors (4,456,432 shares), FRANKLIN RESOURCES INC (4,324,500 shares), Foresite Capital Management II, LLC (4,225,047 shares), MORGAN STANLEY (3,979,635 shares), and MILLENNIUM MANAGEMENT LLC (3,939,973 shares).
This table shows the top 126 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.